MDI Project Trial Production for Chinese Mononitrobenzene Project

Editor: Dominik Stephan

BASF starts trial production of mononitrobenzene in Chongqing. This project is a first precursor plant of a world-sacle integrated MDI complex

Related Companies

The Chinese mononitrobenzene plant is one part of RMB 8 billion (approx. €860 million) BASF investment
The Chinese mononitrobenzene plant is one part of RMB 8 billion (approx. €860 million) BASF investment
(Pciture: BASF)

Chongqing/VR China – Chemicals giant BASF has begun trial operations at the mononitrobenzene plant within the integrated 400,000 metric ton methylene diphenyl diisocyanate (MDI) complex in Chongqing, China. Mononitrobenzene is a precursor for the production of MDI.

This MDI site covers an area of more than 50 hectares, including facilities of 400,000 metric tons per year of Mononitrobenzene, 300,000 metric tons per year of aniline, 400,000 metric tons per year of crude MDI, and an MDI splitter with a capacity of 400,000 metric tons per year.

(ID:43355194)